| New strategies for targeting drug combinations to overcome mutation-driven drug resistance | |
| Xu, Menglin; Wang, Linyan; Wang, Haiyun; Song, Dongli; Liebmen, Michael | |
| 刊名 | SEMINARS IN CANCER BIOLOGY
 |
| 2017 | |
| 卷号 | 42 |
| 关键词 | Drug resistance Lung cancer Precision medicine Pharmacogenomics profile CRISPR-Cas9 screening Pathway-centric therapy |
| ISSN号 | 1044-579X |
| URL标识 | 查看原文 |
| 语种 | 英语 |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/3623215 |
| 专题 | 复旦大学上海医学院 |
| 推荐引用方式 GB/T 7714 | Xu, Menglin,Wang, Linyan,Wang, Haiyun,et al. New strategies for targeting drug combinations to overcome mutation-driven drug resistance[J]. SEMINARS IN CANCER BIOLOGY,2017,42. |
| APA | Xu, Menglin,Wang, Linyan,Wang, Haiyun,Song, Dongli,&Liebmen, Michael.(2017).New strategies for targeting drug combinations to overcome mutation-driven drug resistance.SEMINARS IN CANCER BIOLOGY,42. |
| MLA | Xu, Menglin,et al."New strategies for targeting drug combinations to overcome mutation-driven drug resistance".SEMINARS IN CANCER BIOLOGY 42(2017). |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论